{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:39Z","timestamp":1753890999535,"version":"3.41.2"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The contribution of natural killer (NK) cells to tumor rejection in the context of programmed death-ligand 1\/programmed death 1 (PD-L1\/PD-1) blockade is a matter of intense debate. To elucidate the role of PD-L1 expression on tumor cells and the functional consequences of engaging PD-1 receptor on cytotoxic cells, PD-L1 expression was genetically inactivated and WT or PD-L1-deficient parental tumor cells were adoptively transferred intravenously into F1 recipients. The engraftment of PD-L1-deficient A20 tumor cells in the spleen and liver of F1 recipients was impaired compared with A20 PD-L1 WT tumor counterparts. To elucidate the mechanism responsible for this differential tumor engraftment and determine the relevance of the role of the PD-L1\/PD-1 pathway in the interplay of tumor cells\/NK cells, a short-term competitive tumor implantation assay in the peritoneal cavity of semiallogeneic F1 recipients was designed. The results presented herein showed that NK cells killed target tumor cells with similar efficiency regardless of PD-L1 expression, whereas PD-L1 expression on A20 tumor cells conferred significant tumor protection against rejection by CD8 T cells confirming the role of the co-inhibitory receptor PD-1 in the modulation of their cytotoxic activity. In summary, PD-L1 expression on A20 leukemia tumor cells modulates CD8 T-cell-mediated responses to tumor-specific antigens but does not contribute to inhibit NK cell-mediated hybrid resistance, which correlates with the inability to detect PD-1 expression on NK cells neither under steady-state conditions nor under inflammatory conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2022.887348","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T05:01:19Z","timestamp":1655701279000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1\/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria-Luisa","family":"del Rio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Antonio","family":"Perez-Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Ignacio","family":"Rodriguez-Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In Search of the 'Missing Self': MHC Molecules and NK Cell Recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800267-4.00003-1","article-title":"Recognition of Tumors by the Innate Immune System and Natural Killer Cells","volume":"122","author":"Marcus","year":"2014","journal-title":"Adv Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01295","article-title":"Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102129","article-title":"Control of NK Cell Activation by Immune Checkpoint Molecules","volume":"18","author":"Beldi-Ferchiou","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.144.3624.1339","article-title":"Hybrid Resistance to Parental Marrow Grafts: Association With the K Region of H-2","volume":"144","author":"Cudkowicz","year":"1964","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.134.6.1513","article-title":"Peculiar Immunobiology of Bone Marrow Allografts. II. Rejection of Parental Grafts by Resistant F 1 Hybrid Mice","volume":"134","author":"Cudkowicz","year":"1971","journal-title":"J Exp Med"},{"key":"B7","article-title":"Histocompatibility Genes of the Mouse. II. Production and Analysis of Isogenic Resistant Lines","volume":"21","author":"Snell","year":"1958","journal-title":"J Natl Cancer Inst"},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.iy.10.040192.001201","article-title":"Murine Natural Killer Cells and Marrow Graft Rejection","volume":"10","author":"Yu","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200111)31:11<3147::AID-IMMU3147>3.0.CO;2-F","article-title":"Critical Role of NK But Not NKT Cells in Acute Rejection of Parental Bone Marrow Cells in F1 Hybrid Mice","volume":"31","author":"Suzue","year":"2001","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.154.6.2568","article-title":"Hybrid and Allogeneic Resistance to T Cell Grafts Mediated by Murine NK and CD8+ T Cells","volume":"154","author":"Davenport","year":"1995","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.159.4.1132","article-title":"Natural Resistance of Lethally Irradiated F1 Hybrid Mice to Parental Marrow Grafts is a Function of H-2\/Hh-Restricted Effectors","volume":"159","author":"Daley","year":"1984","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced Expression of PD-1, A Novel Member of the Immunoglobulin Gene Superfamily, Upon Programmed Cell Death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on Tumor Cells in the Escape From Host Immune System and Tumor Immunotherapy by PD-L1 Blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02520-z","article-title":"Critical Role of PD-L1 Expression on non-Tumor Cells Rather Than on Tumor Cells for Effective Anti-PD-L1 Immunotherapy in a Transplantable Mouse Hematopoietic Tumor Model","volume":"69","author":"Rodriguez-Barbosa","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954","article-title":"PD-1 Blockade Induces Responses by Inhibiting Adaptive Immune Resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396","article-title":"PD-1 Expression by Tumour-Associated Macrophages Inhibits Phagocytosis and Tumour Immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.04.001","article-title":"Macrophages as Mediators of Tumor Immunosurveillance","volume":"31","author":"Jaiswal","year":"2010","journal-title":"Trends Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.tranon.2020.100825","article-title":"Tumor-Associated Neutrophils Suppress Antitumor Immunity of NK Cells Through the PD-L1\/PD-1 Axis","volume":"13","author":"Sun","year":"2020","journal-title":"Transl Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133353","article-title":"Minimal PD-1 Expression in Mouse and Human NK Cells Under Diverse Conditions","volume":"130","author":"Judge","year":"2020","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137051","article-title":"Programmed Cell Death Protein 1 on Natural Killer Cells: Fact or Fiction","volume":"130","author":"Cho","year":"2020","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123121","article-title":"NK Cells for PD-1\/PD-L1 Blockade Immunotherapy: Pinning Down the NK Cell","volume":"128","author":"Dunai","year":"2018","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1509819","article-title":"PD-L1 Blockade Enhances Anti-Tumor Efficacy of NK Cells","volume":"7","author":"Oyer","year":"2018","journal-title":"Oncoimmunology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK Cells to Immunotherapy Mediated by PD-1\/PD-L1 Blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500221454x","article-title":"The Natural History of a Novel, Systemic, Disseminated Model of Syngeneic Mouse B-Cell Lymphoma","volume":"46","author":"Passineau","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and Characterization of BALB\/c Lymphoma Lines With B Cell Properties","volume":"122","author":"Kim","year":"1979","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-1862-1_10","article-title":"Genome Engineering Using CRISPR-Cas9 System","volume":"1239","author":"Cong","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.143","article-title":"Genome Engineering Using the CRISPR-Cas9 System","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3047","article-title":"Improved Vectors and Genome-Wide Libraries for CRISPR Screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.10.5538","article-title":"Expression of Programmed Death 1 Ligands by Murine T Cells and APC","volume":"169","author":"Yamazaki","year":"2002","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.9.1611","article-title":"An Essential Role for Tumor Necrosis Factor in Natural Killer Cell-Mediated Tumor Rejection in the Peritoneum","volume":"188","author":"Smyth","year":"1998","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2021.08.006","article-title":"The Impact of CD160 Deficiency on Alloreactive CD8 T Cell Responses and Allograft Rejection","volume":"239","author":"Del Rio","year":"2021","journal-title":"Transl Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a Monoclonal Antibody Directed Against Mouse Macrophage and Lymphocyte Fc Receptors","volume":"150","author":"Unkeless","year":"1979","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of Lupus-Like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0798-z","article-title":"Cis-Trans Interactions of Cell Surface Receptors: Biological Roles and Structural Basis","volume":"68","author":"Held","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 Function by Cis-PD-L1\/CD80 Interactions is Required for Optimal T Cell Responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0316","article-title":"PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface","volume":"6","author":"Chaudhri","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","article-title":"PD-L1:CD80 Cis-Heterodimer Triggers the Co-Stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways","volume":"51","author":"Zhao","year":"2019","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The Blockade of Immune Checkpoints in Cancer Immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.345","article-title":"The Rap GTPases Regulate the Migration, Invasiveness and In Vivo Dissemination of B-Cell Lymphomas","volume":"29","author":"Lin","year":"2010","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200112270-00016","article-title":"Differential Expression of Chemokines and Chemokine Receptors Shapes the Inflammatory Response in Rejecting Human Liver Transplants","volume":"72","author":"Goddard","year":"2001","journal-title":"Transplantation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/319675a0","article-title":"Selective Rejection of H-2-Deficient Lymphoma Variants Suggests Alternative Immune Defence Strategy","volume":"319","author":"Karre","year":"1986","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1995.0016","article-title":"Hybrid Resistance: 'Negative' and 'Positive' Signaling of Murine Natural Killer Cells","volume":"7","author":"Bennett","year":"1995","journal-title":"Semin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(93)90342-I","article-title":"Genetic Resistance to Lymphoma-Leukemia: Role of Natural Killer Cells in the Rejection of Lymphoma Grafts","volume":"47","author":"Datta","year":"1993","journal-title":"BioMed Pharmacother"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15146","article-title":"Hybrid Resistance to Parental Bone Marrow Grafts in Non-Lethally Irradiated Mice","volume":"19","author":"Mahr","year":"2018","journal-title":"Am J Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-Sensing Receptors in Sterile Inflammation and Inflammatory Diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02986826","article-title":"Pillars Article: Methods for the Study of Histocompatibility Genes","volume":"49","author":"Snell","year":"2014","journal-title":"J Genet"},{"key":"B50","first-page":"75","article-title":"The Genetics of Tissue Transplantation in Mammals","volume":"8","author":"Little","year":"1924","journal-title":"J Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.134.1.83","article-title":"Peculiar Immunobiology of Bone Marrow Allografts. I. Graft Rejection by Irradiated Responder Mice","volume":"134","author":"Cudkowicz","year":"1971","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.5.1499","article-title":"Acute Rejection of Murine Bone Marrow Allografts by Natural Killer Cells and T Cells. Differences in Kinetics and Target Antigens Recognized","volume":"166","author":"Murphy","year":"1987","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80158-6","article-title":"Role of Murine NK Cells and Their Receptors in Hybrid Resistance","volume":"9","author":"Kumar","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00324.x","article-title":"Clarence Cook Little, (1888-1971): The Genetic Basis of Transplant Immunology","volume":"4","author":"Auchincloss","year":"2004","journal-title":"Am J Transplant"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01864.x","article-title":"NK Cells Rapidly Reject Allogeneic Bone Marrow in the Spleen Through a Perforin- and Ly49D-Dependent, But NKG2D-Independent Mechanism","volume":"7","author":"Hamby","year":"2007","journal-title":"Am J Transplant"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0171","article-title":"Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade","volume":"2","author":"Da Silva","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 Axis Modulates the Natural Killer Cell Versus Multiple Myeloma Effect: A Therapeutic Target for CT-011, a Novel Monoclonal Anti-PD-1 Antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1557030","DOI":"10.1080\/2162402X.2018.1557030","article-title":"PD-1 in Human NK Cells: Evidence of Cytoplasmic mRNA and Protein Expression","volume":"8","author":"Mariotti","year":"2019","journal-title":"Oncoimmunology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10235","article-title":"PD1 Blockade Enhances Cytotoxicity of In Vitro Expanded Natural Killer Cells Towards Myeloma Cells","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01242","article-title":"PD\/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells","volume":"10","author":"Pesce","year":"2019","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00007","article-title":"Indirect Impact of PD-1\/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion","volume":"11","author":"Alvarez","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011","article-title":"Predictive Correlates of Response to the Anti-PD-L1 Antibody MPDL3280A in Cancer Patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502291","article-title":"NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming Through PD-1\/PD-L1 Interactions With Dendritic Cells","volume":"197","author":"Iraolagoitia","year":"2016","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The Mechanism of Anti-PD-L1 Antibody Efficacy Against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discovery"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.137.11.3420","article-title":"The Effects of Polyinosinic:Polycytidylic Acid (Pi:C) on the Graft-vs-Host (GVH) Reaction. II. Increased NK-Mediated Rejection on C57BL\/6 Lymphocytes by (C57BL\/6 X A)F1 Mice","volume":"137","author":"Peres","year":"1986","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/07357908309040929","article-title":"Aging of Natural and Acquired Immunity of Mice. I. Decreased Natural Killer Cell Function and Hybrid Resistance","volume":"1","author":"Fitzgerald","year":"1983","journal-title":"Cancer Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199601150-00024","article-title":"Natural Killer Cells Weakly Resist Engraftment of Allogeneic, Long-Term, Multilineage-Repopulating Hematopoietic Stem Cells","volume":"61","author":"Lee","year":"1996","journal-title":"Transplantation"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747392","article-title":"The Bone Marrow is Not Only a Primary Lymphoid Organ: The Critical Role for T Lymphocyte Migration and Housing of Long-Term Memory Plasma Cells","volume":"48","author":"Pabst","year":"2018","journal-title":"Eur J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0750","article-title":"Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8(+) T Cells in Murine Syngeneic Tumor Models","volume":"7","author":"Xiong","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2016.09.004","article-title":"Modulation of Cytotoxic Responses by Targeting CD160 Prolongs Skin Graft Survival Across Major Histocompatibility Class I Barrier","volume":"181","author":"Del Rio","year":"2017","journal-title":"Transl Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1132130","article-title":"Immunotherapeutic Targeting of LIGHT\/LTbetaR\/HVEM Pathway Fully Recapitulates the Reduced Cytotoxic Phenotype of LIGHT-Deficient T Cells","volume":"8","author":"Del Rio","year":"2016","journal-title":"MAbs"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830181125","article-title":"Ly-6C is a Monocyte\/Macrophage and Endothelial Cell Differentiation Antigen Regulated by Interferon-Gamma","volume":"18","author":"Jutila","year":"1988","journal-title":"Eur J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer Immunotherapy Using Checkpoint Blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/cmi.2015.101","article-title":"T Follicular Helper Expansion and Humoral-Mediated Rejection are Independent of the HVEM\/BTLA Pathway","volume":"14","author":"Rodriguez-Barbosa","year":"2017","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.887348\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T20:16:38Z","timestamp":1675887398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.887348\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2022.887348"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.887348","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"article-number":"887348"}}